JA
Insider
Jack Anders
Chief Financial OfficerJack Anders (Chief Financial Officer) filed 8 Form 4 reports in the trailing twelve months (0 purchases, 8 sales), most often in Revolution Medicines, Inc. (RVMD). The largest single filing was $3.3M of RVMD (19,700 sh across 3 lots, as filed), executed Jun 24.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
8
0 buys · 8 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$7.1M
shares × price, as filed
Last traded
Sep 16
Filed Sep 18
Median ADV $548.2M across their filed names
Open performance→Volume by month
Buys $0
Sells $8.2M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
8 filings
Sector per market data · by filing · past 12 months
Most traded names
RVMDRecent filings
RVMDSALE
Revolution Medicines, Inc.
View filing →
$106K2,320 sh × $45.82
Exec Sep 16 2025
Filed Sep 18 2025 · 5:30 PM ET RVMDSALE Revolution Medicines, Inc. View filing → $401K
10,000 sh across 2 lots
Exec Sep 2 2025
Filed Sep 4 2025 · 5:30 PM ET RVMDSALE Revolution Medicines, Inc. View filing → $120K
2,635 sh × $45.40
Exec Dec 16 2024
Filed Dec 18 2024 · 5:30 PM ET RVMDSALE Revolution Medicines, Inc. View filing → $503K
10,000 sh × $50.30
Exec Oct 11 2024
Filed Oct 15 2024 · 5:30 PM ET